Detalhe da pesquisa
1.
Letter to the Editor on Cross-Protection of RotaTeq.
J Pediatr
; 268: 113952, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38336206
2.
Efficacy and safety of sitagliptin added to treatment of patients with type 2 diabetes inadequately controlled with premixed insulin.
Diabetes Obes Metab
; 21(2): 408-411, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30178570
3.
A phase 3 randomized, open-label study evaluating the immunogenicity and safety of concomitant and staggered administration of a live, pentavalent rotavirus vaccine and an inactivated poliomyelitis vaccine in healthy infants in China.
Hum Vaccin Immunother
; 20(1): 2324538, 2024 Dec 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-38509699
4.
Immunogenicity and safety of quadrivalent and 9-valent human papillomavirus vaccines in Indian clinical trial participants.
Hum Vaccin Immunother
; 18(6): 2105067, 2022 Nov 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-35997582
5.
Design of a phase III efficacy, immunogenicity, and safety study of 9-valent human papillomavirus vaccine in prevention of oral persistent infection in men.
Contemp Clin Trials
; 115: 106592, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-34678491
6.
Efficacy and tolerability of a single-pill combination of amlodipine/valsartan in Asian hypertensive patients not adequately controlled with valsartan monotherapy.
Clin Exp Hypertens
; 33(3): 179-86, 2011.
Artigo
em Inglês
| MEDLINE | ID: mdl-21466389
7.
Safety, tolerability, and immunogenicity of V114, a 15-valent pneumococcal conjugate vaccine, followed by sequential PPSV23 vaccination in healthy adults agedâ¯≥50â¯years: A randomized phase III trial (PNEU-PATH).
Vaccine
; 39(43): 6422-6436, 2021 10 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-34489128
8.
Differential HbA1c response in the placebo arm of DPP-4 inhibitor clinical trials conducted in China compared to other countries: a systematic review and meta-analysis.
BMC Pharmacol Toxicol
; 17(1): 40, 2016 09 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-27600598
9.
Efficacy and safety of aliskiren, a direct renin inhibitor, compared with ramipril in Asian patients with mild to moderate hypertension.
Hypertens Res
; 35(1): 28-33, 2012 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-21900941